Evaluation of the clinical relevance and limitations of current pre-clinical models of peripheral artery disease

Clinical Science

Volumn 130, Issue 3, 2016, Pages 127-150

  Krishna, Smriti Murali ^a   Omer, Safraz Mohamed ^a   Golledge, Jonathan ^a,b  

^a JAMES COOK UNIVERSITY   (Australia)

^b TOWNSVILLE HOSPITAL   (Australia)

Author keywords

Angiogenesis; Animal model; Arteriogenesis; Atherosclerosis; Critical limb ischaemia; Hind limb ischaemia; Peripheral arterial disease

Indexed keywords

RECOMBINANT FIBROBLAST GROWTH FACTOR;

ADULT STEM CELL; ANGIOGENESIS; ANIMAL MODEL; ARTERY OCCLUSION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW DERIVED MESENCHYMAL STEM CELL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DYSLIPIDEMIA; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; GENETIC VARIABILITY; GROUPS BY AGE; HISTOPATHOLOGY; HYPERTENSION; LEG ISCHEMIA; LIMB ISCHEMIA; MICRO-COMPUTED TOMOGRAPHY; MULTIDETECTOR COMPUTED TOMOGRAPHY; MUSCLE NECROSIS; MUSCLE STEM CELL; MYOSITIS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OBESITY; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PLURIPOTENT STEM CELL; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; REVIEW; RISK FACTOR; SEX DIFFERENCE; SMOKING; THROMBOEMBOLISM; ANIMAL; DISEASE MODEL; HUMAN; PERIPHERAL ARTERIAL DISEASE; VASCULAR SURGERY;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; PERIPHERAL ARTERIAL DISEASE; RISK FACTORS; VASCULAR SURGICAL PROCEDURES;

EID: 84951922165     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20150435     Document Type: Review

References (187)

1. Weitz, J.I., Byrne, J., Clagett, G.P., Farkouh, M.E., Porter, J.M., Sackett, D.L., Strandness, Jr., D.E. and Taylor, L.M. (1996) Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 94, 3026-3049
2. Norman, P.E., Eikelboom, J.W. and Hankey, G.J. (2004) Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications. Med. J. Aust. 181, 150-154
3. Bergiers, S., Vaes, B. and Degryse, J. (2011) To screen or not to screen for peripheral arterial disease in subjects aged 80 and over in primary health care: a cross-sectional analysis from the BELFRAIL study. BMC Fam. Pract. 12, 39
4. Walker, T.G. (2009) Acute limb ischemia. Tech. Vasc. Interv. Radiol. 12, 117-129
5. Norgren, L., Hiatt, W.R., Dormandy, J.A., Nehler, M.R., Harris, K.A., Fowkes, F.G., Group, T.I.W., Bell, K., Caporusso, J., Durand-Zaleski, I. et al. (2007) Inter-Society consensus for the management of peripheral arterial disease (TASC II). Eur. J. Vasc. Endovasc. Surg. 33 (Suppl 1), S1-S75
6. Arnold, T.E. and Kerstein, M.D. (2000) Secondary distal extension of infrainguinal bypass: long-term limb and patient survival. Ann. Vasc. Surg. 14, 450-456
7. Brumberg, R.S., Back, M.R., Armstrong, P.A., Cuthbertson, D., Shames, M.L., Johnson, B.L. and Bandyk, D.F. (2007) The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure. J. Vasc. Surg. 46, 1160-1166
8. Sigvant, B., Wiberg-Hedman, K., Bergqvist, D., Rolandsson, O., Andersson, B., Persson, E. and Wahlberg, E. (2007) A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J. Vasc. Surg. 45, 1185-1191
9. Peacock, J.M., Keo, H.H., Duval, S., Baumgartner, I., Oldenburg, N.C., Jaff, M.R., Henry, T.D., Yu, X. and Hirsch, A.T. (2011) The incidence and health economic burden of ischemic amputation in Minnesota, 2005-2008. Prev. Chronic. Dis. 8, A141
10. Meijer, W.T., Grobbee, D.E., Hunink, M.G., Hofman, A. and Hoes, A.W. (2000) Determinants of peripheral arterial disease in the elderly: the Rotterdam study. Arch. Intern. Med. 160, 2934-2938
11. Norgren, L., Hiatt, W.R., Dormandy, J.A., Nehler, M.R., Harris, K.A., Fowkes, F.G. and Group, T.I.W. (2007) Inter-Society consensus for the management of peripheral arterial disease (TASC II). J. Vasc. Surg. 45 (Suppl S), S5-S67
12. Koskela, V.K., Salenius, J. and Suominen, V. (2011) Peripheral arterial disease in octogenarians and nonagenarians: factors predicting survival. Ann. Vasc. Surg. 25, 169-176
13. Lo, R.C., Bensley, R.P., Dahlberg, S.E., Matyal, R., Hamdan, A.D., Wyers, M., Chaikof, E.L. and Schermerhorn, M.L. (2014) Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease. J. Vasc. Surg. 59, 409-418 e3
14. Lindgren, H., Gottsater, A., Hermansson, K., Qvarfordt, P. and Bergman, S. (2012) Gender differences in outcome after stent treatment of lesions in the femoropopliteal segment. Scand. J. Surg. 101, 177-183
15. Nestares, T., Lopez-Jurado, M., Urbano, G., Seiquer, I., Ramirez-Tortosa, M.C., Ros, E., Mataix, J. and Gil, A. (2003) Effects of lifestyle modification and lipid intake variations on patients with peripheral vascular disease. Int. J. Vitam. Nutr. Res. 73, 389-398
16. Jones, W.S., Dolor, R.J., Hasselblad, V., Vemulapalli, S., Subherwal, S., Schmit, K., Heidenfelder, B. and Patel, M.R. (2014) Comparative effectiveness of endovascular and surgical revascularization for patients with peripheral artery disease and critical limb ischemia: systematic review of revascularization in critical limb ischemia. Am. Heart J. 167, 489-498 e7
17. Aranguren, X.L., Verfaillie, C.M. and Luttun, A. (2009) Emerging hurdles in stem cell therapy for peripheral vascular disease. J. Mol. Med. 87, 3-16
18. Davies, M.G. (2012) Critical limb ischemia: cell and molecular therapies for limb salvage. Methodist Debakey Cardiovasc. J. 8, 20-27
19. Gupta, R., Tongers, J. and Losordo, D.W. (2009) Human studies of angiogenic gene therapy. Circ. Res. 105, 724-736
20. Krishna, S.M., Trollope, A.F. and Golledge, J. (2015) The relevance of epigenetics to occlusive cerebral and peripheral arterial disease. Clin. Sci. 128, 537-558
21. Dragneva, G., Korpisalo, P. and Yla-Herttuala, S. (2013) Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success. Dis. Model Mech. 6, 312-322
22. Buschmann, I. and Schaper, W. (1999) Arteriogenesis versus angiogenesis: two mechanisms of vessel growth. News Physiol. Sci. 14, 121-125
23. Segers, V.F., Revin, V., Wu, W., Qiu, H., Yan, Z., Lee, R.T. and Sandrasagra, A. (2011) Protease-resistant stromal cell-derived factor-1 for the treatment of experimental peripheral artery disease. Circulation 123, 1306-15
24. Allison, B., Yang, Y., Pourrier, M. and Gibson, J.K. (2011) Comparison of the in vivo hemodynamic effects of the antiarrhythmic agents vernakalant and flecainide in a rat hindlimb perfusion model. J. Cardiovasc. Pharmacol. 57, 463-468
25. Lederman, R.J., Mendelsohn, F.O., Anderson, R.D., Saucedo, J.F., Tenaglia, A.N., Hermiller, J.B., Hillegass, W.B., Rocha-Singh, K., Moon, T.E., Whitehouse, M.J. et al. (2002) Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet 359, 2053-2058
26. Rajagopalan, S., Mohler, III, E.R., Lederman, R.J., Mendelsohn, F.O., Saucedo, J.F., Goldman, C.K., Blebea, J., Macko, J., Kessler, P.D., Rasmussen, H.S. and Annex, B.H. (2003) Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 108, 1933-1938
27. Grossman, P.M., Mendelsohn, F., Henry, T.D., Hermiller, J.B., Litt, M., Saucedo, J.F., Weiss, R.J., Kandzari, D.E., Kleiman, N., Anderson, R.D. et al. (2007) Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease. Am. Heart J. 153, 874-880
28. Belch, J., Hiatt, W.R., Baumgartner, I., Driver, I.V., Nikol, S., Norgren, L., Van Belle, E. and Committees, T. (2011) Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet 377, 1929-1937
29. Kalka, C. and Baumgartner, I. (2008) Gene and stem cell therapy in peripheral arterial occlusive disease. Vasc. Med. 13, 157-172
30. Kim, A.K., Kim, M.H., Kim, S., Oh, W., Hong, H.K., Kang, K.S., Kim, B.S. and Kim, D.I. (2011) Stem-cell therapy for peripheral arterial occlusive disease. Eur. J. Vasc. Endovasc. Surg. 42, 667-675
31. Sica, V., Williams-Ignarro, S., de Nigris, F., D'Armiento, F.P., Lerman, L.O., Balestrieri, M.L., Maione, C., Palagiano, A., Rossiello, L., Ignarro, L.J. and Napoli, C. (2006) Autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the diabetic mouse hindlimb. Cell Cycle 5, 2903-2908
32. Hellingman, A.A., Zwaginga, J.J., van Beem, R.T., Te, R.M.S.M.C., Hamming, J.F., Fibbe, W.E., Quax, P.H. and Geutskens, S.B. (2011) T-cell-pre-stimulated monocytes promote neovascularisation in a murine hind limb ischaemia model. Eur. J. Vasc. Endovasc. Surg. 41, 418-428
33. Aicher, A., Heeschen, C., Sasaki, K., Urbich, C., Zeiher, A.M. and Dimmeler, S. (2006) Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation 114, 2823-2830
34. Griese, D.P., Ehsan, A., Melo, L.G., Kong, D., Zhang, L., Mann, M.J., Pratt, R.E., Mulligan, R.C. and Dzau, V.J. (2003) Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 108, 2710-2715
35. Kedziorek, D.A., Hofmann, L.V., Fu, Y., Gilson, W.D., Cosby, K.M., Kohl, B., Barnett, B.P., Simons, B.W., Walczak, P., Bulte, J.W. et al. (2012) X-ray-visible microcapsules containing mesenchymal stem cells improve hind limb perfusion in a rabbit model of peripheral arterial disease. Stem Cells 30, 1286-1296
36. Park, H.S., Hahn, S., Choi, G.H., Yoo, Y.S., Lee, J.Y. and Lee, T. (2013) Muscle-derived stem cells promote angiogenesis and attenuate intimal hyperplasia in different murine vascular disease models. Stem Cells Dev. 22, 866-877
37. Harada, Y., Yamamoto, Y., Tsujimoto, S., Matsugami, H., Yoshida, A. and Hisatome, I. (2013) Transplantation of freshly isolated adipose tissue-derived regenerative cells enhances angiogenesis in a murine model of hind limb ischemia. Biomed. Res. 34, 23-29
38. Rissanen, T.T., Korpisalo, P., Markkanen, J.E., Liimatainen, T., Orden, M.R., Kholova, I., de Goede, A., Heikura, T., Grohn, O.H. and Yla-Herttuala, S. (2005) Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis. Circulation 112, 3937-3946
39. Korpisalo, P., Karvinen, H., Rissanen, T.T., Kilpijoki, J., Marjomaki, V., Baluk, P., McDonald, D.M., Cao, Y., Eriksson, U., Alitalo, K. and Yla-Herttuala, S. (2008) Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogenic vessels. Circ. Res. 103, 1092-1099
40. Rissanen, T.T., Markkanen, J.E., Gruchala, M., Heikura, T., Puranen, A., Kettunen, M.I., Kholova, I., Kauppinen, R.A., Achen, M.G., Stacker, S.A. et al. (2003) VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ. Res. 92, 1098-1106
41. Pinkenburg, O., Pfosser, A., Hinkel, R., Bottcher, M., Dinges, C., Lebherz, C., Sultana, S., Enssle, J., El-Aouni, C., Buning, H. et al. (2009) Recombinant adeno-associated virus-based gene transfer of cathelicidin induces therapeutic neovascularization preferentially via potent collateral growth. Hum. Gene Ther. 20, 159-167
42. Rissanen, T.T., Markkanen, J.E., Arve, K., Rutanen, J., Kettunen, M.I., Vajanto, I., Jauhiainen, S., Cashion, L., Gruchala, M., Narvanen, O. et al. (2003) Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model. FASEB J. 17, 100-102
43. Li, M., Liu, C., Bin, J., Wang, Y., Chen, J., Xiu, J., Pei, J., Lai, Y., Chen, D. and Fan, C. (2011) Mutant hypoxia inducible factor-1alpha improves angiogenesis and tissue perfusion in ischemic rabbit skeletal muscle. Microvasc. Res. 81, 26-33
44. Patel, T.H., Kimura, H., Weiss, C.R., Semenza, G.L. and Hofmann, L.V. (2005) Constitutively active HIF-1alpha improves perfusion and arterial remodeling in an endovascular model of limb ischemia. Cardiovasc. Res. 68, 144-154
45. Pyun, W.B., Hahn, W., Kim, D.S., Yoo, W.S., Lee, S.D., Won, J.H., Rho, B.S., Park, Z.Y., Kim, J.M. and Kim, S. (2010) Naked DNA expressing two isoforms of hepatocyte growth factor induces collateral artery augmentation in a rabbit model of limb ischemia. Gene Ther. 17, 1442-1452
46. Korpisalo, P., Rissanen, T.T., Bengtsson, T., Liimatainen, T., Laidinen, S., Karvinen, H., Markkanen, J.E., Grohn, O.H. and Yla-Herttuala, S. (2008) Therapeutic angiogenesis with placental growth factor improves exercise tolerance of ischaemic rabbit hindlimbs. Cardiovasc. Res. 80, 263-270
47. Taniyama, Y., Morishita, R., Aoki, M., Nakagami, H., Yamamoto, K., Yamazaki, K., Matsumoto, K., Nakamura, T., Kaneda, Y. and Ogihara, T. (2001) Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease. Gene Ther. 8, 181-189
48. Olea, F.D., Vera Janavel, G., Cuniberti, L., Yannarelli, G., Cabeza Meckert, P., Cors, J., Valdivieso, L., Lev, G., Mendiz, O., Bercovich, A. et al. (2009) Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia. Gene Ther. 16, 716-723
49. Takeshita, S., Weir, L., Chen, D., Zheng, L.P., Riessen, R., Bauters, C., Symes, J.F., Ferrara, N. and Isner, J.M. (1996) Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochem. Biophys. Res. Commun. 227, 628-635
50. Sugano, M., Tsuchida, K., Maeda, T. and Makino, N. (2007) SiRNA targeting SHP-1 accelerates angiogenesis in a rat model of hindlimb ischemia. Atherosclerosis 191, 33-39
51. Gowdak, L.H., Poliakova, L., Wang, X., Kovesdi, I., Fishbein, K.W., Zacheo, A., Palumbo, R., Straino, S., Emanueli, C., Marrocco-Trischitta, M. et al. (2000) Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia. Circulation 102, 565-571
52. Yasumura, E.G., Stilhano, R.S., Samoto, V.Y., Matsumoto, P.K., de Carvalho, L.P., Valero Lapchik, V.B. and Han, S.W. (2012) Treatment of mouse limb ischemia with an integrative hypoxia-responsive vector expressing the vascular endothelial growth factor gene. PLoS One 7, e33944
53. Masaki, I., Yonemitsu, Y., Yamashita, A., Sata, S., Tanii, M., Komori, K., Nakagawa, K., Hou, X., Nagai, Y., Hasegawa, M. et al. (2002) Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ. Res. 90, 966-973
54. Emanueli, C., Graiani, G., Salis, M.B., Gadau, S., Desortes, E. and Madeddu, P. (2004) Prophylactic gene therapy with human tissue kallikrein ameliorates limb ischemia recovery in type 1 diabetic mice. Diabetes 53, 1096-1103
55. Aitsebaomo, J., Srivastava, S., Zhang, H., Jha, S., Wang, Z., Winnik, S., Veleva, A.N., Pi, X., Lockyer, P., Faber, J.E. and Patterson, C. (2011) Recombinant human interleukin-11 treatment enhances collateral vessel growth after femoral artery ligation. Arterioscler Thromb. Vasc. Biol. 31, 306-312
56. Becit, N., Ceviz, M., Kocak, H., Yekeler, I., Unlu, Y., Celenk, C. and Akin, Y. (2001) The effect of vascular endothelial growth factor on angiogenesis: an experimental study. Eur. J. Vasc. Endovasc. Surg. 22, 310-316
57. Stasi, M.A., Scioli, M.G., Arcuri, G., Mattera, G.G., Lombardo, K., Marcellini, M., Riccioni, T., De Falco, S., Pisano, C., Spagnoli, L.G. et al. (2010) Propionyl-L-carnitine improves postischemic blood flow recovery and arteriogenetic revascularization and reduces endothelial NADPH-oxidase 4-mediated superoxide production. Arterioscler Thromb. Vasc. Biol. 30, 426-435
58. Rufaihah, A.J., Huang, N.F., Jame, S., Lee, J.C., Nguyen, H.N., Byers, B., De, A., Okogbaa, J., Rollins, M., Reijo-Pera, R. et al. (2011) Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler. Thromb. Vasc. Biol. 31, e72-e79
59. Ouma, G.O., Zafrir, B., Mohler, III, E.R. and Flugelman, M.Y. (2013) Therapeutic angiogenesis in critical limb ischemia. Angiology 64, 466-480
60. Lotfi, S., Patel, A.S., Mattock, K., Egginton, S., Smith, A. and Modarai, B. (2013) Towards a more relevant hind limb model of muscle ischaemia. Atherosclerosis 227, 1-8
61. Malyar, N.M., Radtke, S., Malyar, K., Arjumand, J., Horn, P.A., Kroger, K., Freisinger, E., Reinecke, H., Giebel, B. and Brock, F.E. (2014) Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters. Cytotherapy 16, 1270-1279
62. Lee, H.C., An, S.G., Lee, H.W., Park, J.S., Cha, K.S., Hong, T.J., Park, J.H., Lee, S.Y., Kim, S.P., Kim, Y.D. et al. (2012) Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: a pilot study. Circ. J. 76, 1750-1760
63. Kawamoto, A., Katayama, M., Handa, N., Kinoshita, M., Takano, H., Horii, M., Sadamoto, K., Yokoyama, A., Yamanaka, T., Onodera, R. et al. (2009) Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial. Stem Cells 27, 2857-2864
64. Burt, R.K., Testori, A., Oyama, Y., Rodriguez, H.E., Yaung, K., Villa, M., Bucha, J.M., Milanetti, F., Sheehan, J., Rajamannan, N. and Pearce, W.H. (2010) Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia. Bone Marrow Transplant 45, 111-116
65. Powell, R.J., Simons, M., Mendelsohn, F.O., Daniel, G., Henry, T.D., Koga, M., Morishita, R. and Annex, B.H. (2008) Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation 118, 58-65
66. Kusumanto, Y.H., van Weel, V., Mulder, N.H., Smit, A.J., van den Dungen, J.J., Hooymans, J.M., Sluiter, W.J., Tio, R.A., Quax, P.H., Gans, R.O. et al. (2006) Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Hum. Gene Ther. 17, 683-691
67. Grochot-Przeczek, A., Dulak, J. and Jozkowicz, A. (2013) Therapeutic angiogenesis for revascularization in peripheral artery disease. Gene 525, 220-228
68. Bartel, R.L., Booth, E., Cramer, C., Ledford, K., Watling, S. and Zeigler, F. (2013) From bench to bedside: review of gene and cell-based therapies and the slow advancement into phase 3 clinical trials, with a focus on Aastrom's Ixmyelocel-T. Stem Cell Rev. 9, 373-383
69. Wen, Y., Meng, L. and Gao, Q. (2011) Autologous bone marrow cell therapy for patients with peripheral arterial disease: a meta-analysis of randomized controlled trials. Expert Opin. Biol. Ther. 11, 1581-1589
70. Shintani, S., Murohara, T., Ikeda, H., Ueno, T., Sasaki, K., Duan, J. and Imaizumi, T. (2001) Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 103, 897-903
71. Moon, M.H., Kim, S.Y., Kim, Y.J., Kim, S.J., Lee, J.B., Bae, Y.C., Sung, S.M. and Jung, J.S. (2006) Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia. Cell Physiol. Biochem. 17, 279-290
72. Kang, Y., Park, C., Kim, D., Seong, C.M., Kwon, K. and Choi, C. (2010) Unsorted human adipose tissue-derived stem cells promote angiogenesis and myogenesis in murine ischemic hindlimb model. Microvasc. Res. 80, 310-316
73. Kondo, K., Shintani, S., Shibata, R., Murakami, H., Murakami, R., Imaizumi, M., Kitagawa, Y. and Murohara, T. (2009) Implantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis. Arterioscler. Thromb. Vasc. Biol. 29, 61-66
74. Sumi, M., Sata, M., Toya, N., Yanaga, K., Ohki, T. and Nagai, R. (2007) Transplantation of adipose stromal cells, but not mature adipocytes, augments ischemia-induced angiogenesis. Life Sci. 80, 559-565
75. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G. and Isner, J.M. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967
76. Kalka, C., Masuda, H., Takahashi, T., Kalka-Moll, W.M., Silver, M., Kearney, M., Li, T., Isner, J.M. and Asahara, T. (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. U.S.A. 97, 3422-3427
77. Morishita, R., Nakamura, S., Hayashi, S., Taniyama, Y., Moriguchi, A., Nagano, T., Taiji, M., Noguchi, H., Takeshita, S., Matsumoto, K. et al. (1999) Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 33, 1379-1384
78. Shigematsu, H., Yasuda, K., Iwai, T., Sasajima, T., Ishimaru, S., Ohashi, Y., Yamaguchi, T., Ogihara, T. and Morishita, R. (2010) Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia. Gene Ther. 17, 1152-1161
79. Yonemitsu, Y., Matsumoto, T., Itoh, H., Okazaki, J., Uchiyama, M., Yoshida, K., Onimaru, M., Onohara, T., Inoguchi, H., Kyuragi, R. et al. (2013) DVC1-0101 to treat peripheral arterial disease: a phase I/IIa open-label dose-escalation clinical trial. Mol. Ther. 21, 707-714
80. Fujii, T., Yonemitsu, Y., Onimaru, M., Tanii, M., Nakano, T., Egashira, K., Takehara, T., Inoue, M., Hasegawa, M., Kuwano, H. and Sueishi, K. (2006) Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway. Arterioscler. Thromb. Vasc. Biol. 26, 2483-2489
81. Tabata, H., Silver, M. and Isner, J.M. (1997) Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo: critical role of secretion signal in use of naked DNA. Cardiovasc. Res. 35, 470-479
82. Pu, L.Q., Sniderman, A.D., Brassard, R., Lachapelle, K.J., Graham, A.M., Lisbona, R. and Symes, J.F. (1993) Enhanced revascularization of the ischemic limb by angiogenic therapy. Circulation 88, 208-215
83. Takeshita, S., Zheng, L.P., Brogi, E., Kearney, M., Pu, L.Q., Bunting, S., Ferrara, N., Symes, J.F. and Isner, J.M. (1994) Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. Clin. Invest. 93, 662-670
84. Makinen, K., Manninen, H., Hedman, M., Matsi, P., Mussalo, H., Alhava, E. and Yla-Herttuala, S. (2002) Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol. Ther. 6, 127-133
85. Mack, C.A., Magovern, C.J., Budenbender, K.T., Patel, S.R., Schwarz, E.A., Zanzonico, P., Ferris, B., Sanborn, T., Isom, P., Ferris, B. et al. (1998) Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. J. Vasc. Surg. 27, 699-709
86. Ojalvo, A.G., Seralena, A., Vazquez, R., Montequin, J.F., Vispo, N.S., Silva, R., Aldama, A., Puchades, Y., Sorell, L.T., Lopez-Saura, P. et al. (2003) Therapeutic angiogenesis following intramuscular gene transfer of vascular endothelial growth factor 121 in a dog model of hindlimb ischemia. Electron. J. Biotechnol. 6, 208-222
87. Zhong, J., Eliceiri, B., Stupack, D., Penta, K., Sakamoto, G., Quertermous, T., Coleman, M., Boudreau, N. and Varner, J.A. (2003) Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1. J. Clin. Invest. 112, 30-41
88. Suzuki, H., Shibata, R., Kito, T., Yamamoto, T., Ishii, M., Nishio, N., Ito, S., Isobe, K. and Murohara, T. (2012) Comparative angiogenic activities of induced pluripotent stem cells derived from young and old mice. PLoS One 7, e39562
89. Bickert, T., Marshall, R.P., Zhang, Z., Ludewig, P., Binder, M., Klinke, A., Rottbauer, W., Amling, M., Wagener, C., Ito, W.D. and Horst, A.K. (2012) Acceleration of collateral development by carcinoembryonic antigen-related cell adhesion molecule 1 expression on CD11b/(+)Gr-1(+) myeloid cells-brief report. Arterioscler. Thromb. Vasc. Biol. 32, 2566-2568
90. Nagahama, R., Matoba, T., Nakano, K., Kim-Mitsuyama, S., Sunagawa, K. and Egashira, K. (2012) Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia. Arterioscler. Thromb. Vasc. Biol. 32, 2427-2434
91. Madeddu, P., Emanueli, C., Spillmann, F., Meloni, M., Bouby, N., Richer, C., Alhenc-Gelas, F., Van Weel, V., Eefting, D., Quax, P.H. et al. (2006) Murine models of myocardial and limb ischemia: diagnostic end-points and relevance to clinical problems. Vascul. Pharmacol. 45, 281-301
92. Goto, T., Fukuyama, N., Aki, A., Kanabuchi, K., Kimura, K., Taira, H., Tanaka, E., Wakana, N., Mori, H. and Inoue, H. (2006) Search for appropriate experimental methods to create stable hind-limb ischemia in mouse. Tokai J. Exp. Clin. Med. 31, 128-132
93. Shireman, P.K. and Quinones, M.P. (2005) Differential necrosis despite similar perfusion in mouse strains after ischemia. J. Surg. Res. 129, 242-250
94. Couffinhal, T., Silver, M., Kearney, M., Sullivan, A., Witzenbichler, B., Magner, M., Annex, B., Peters, K. and Isner, J.M. (1999) Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/-mice. Circulation 99, 3188-3198
95. Monsky, W.L., Finitsis, S., De Cicco, D., Brock, J.M., Kucharczyk, J. and Latchaw, R.E. (2011) A novel mechanical thrombectomy device for retrieval of intravascular thrombus. Cardiovasc. Intervent. Radiol. 34, 383-390
96. Laing, S.T., Moody, M., Smulevitz, B., Kim, H., Kee, P., Huang, S., Holland, C.K. and McPherson, D.D. (2011) Ultrasound-enhanced thrombolytic effect of tissue plasminogen activator-loaded echogenic liposomes in an in vivo rabbit aorta thrombus model-brief report. Arterioscler. Thromb. Vasc. Biol. 31, 1357-1359
97. Lee, J.H. (2012) A new rat pain model of thrombus-induced ischemia. Methods Mol. Biol. 851, 213-222
98. Mesquita, R.C., Skuli, N., Kim, M.N., Liang, J., Schenkel, S., Majmundar, A.J., Simon, M.C. and Yodh, A.G. (2010) Hemodynamic and metabolic diffuse optical monitoring in a mouse model of hindlimb ischemia. Biomed. Opt. Express 1, 1173-1187
99. Helisch, A., Wagner, S., Khan, N., Drinane, M., Wolfram, S., Heil, M., Ziegelhoeffer, T., Brandt, U., Pearlman, J.D., Swartz, H.M. and Schaper, W. (2006) Impact of mouse strain differences in innate hindlimb collateral vasculature. Arterioscler. Thromb. Vasc. Biol. 26, 520-526
100. Li, J., Wei, Y., Liu, K., Yuan, C., Tang, Y., Quan, Q., Chen, P., Wang, W., Hu, H. and Yang, L. (2010) Synergistic effects of FGF-2 and PDGF-BB on angiogenesis and muscle regeneration in rabbit hindlimb ischemia model. Microvasc. Res. 80, 10-17
101. Couffinhal, T., Silver, M., Zheng, L.P., Kearney, M., Witzenbichler, B. and Isner, J.M. (1998) Mouse model of angiogenesis. Am. J. Pathol. 152, 1667-1679
102. Turgeon, J., Dussault, S., Haddad, P., Groleau, J., Menard, C., Michaud, S.E., Maingrette, F. and Rivard, A. (2010) Probucol and antioxidant vitamins rescue ischemia-induced neovascularization in mice exposed to cigarette smoke: potential role of endothelial progenitor cells. Atherosclerosis 208, 342-349
103. Togliatto, G., Trombetta, A., Dentelli, P., Cotogni, P., Rosso, A., Tschop, M.H., Granata, R., Ghigo, E. and Brizzi, M.F. (2013) Unacylated ghrelin promotes skeletal muscle regeneration following hindlimb ischemia via SOD-2-mediated miR-221/222 expression. J. Am. Heart Assoc. 2, e000376
104. Hazarika, S., Angelo, M., Li, Y., Aldrich, A.J., Odronic, S.I., Yan, Z., Stamler, J.S. and Annex, B.H. (2008) Myocyte specific overexpression of myoglobin impairs angiogenesis after hind-limb ischemia. Arterioscler. Thromb. Vasc. Biol. 28, 2144-2150
105. Li, Y., Hazarika, S., Xie, D., Pippen, A.M., Kontos, C.D. and Annex, B.H. (2007) In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia. Diabetes 56, 656-665
106. Hazarika, S., Dokun, A.O., Li, Y., Popel, A.S., Kontos, C.D. and Annex, B.H. (2007) Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1. Circ. Res. 101, 948-956
107. Napoli, C., Williams-Ignarro, S., de Nigris, F., de Rosa, G., Lerman, L.O., Farzati, B., Matarazzo, A., Sica, G., Botti, C., Fiore, A. et al. (2005) Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb. Proc. Natl. Acad. Sci. U.S.A. 102, 17202-17206
108. Morimoto, Y., Bando, Y.K., Shigeta, T., Monji, A. and Murohara, T. (2011) Atorvastatin prevents ischemic limb loss in type 2 diabetes: role of p53. J. Atheroscler. Thromb. 18, 200-208
109. Yang, Y., Tang, G., Yan, J., Park, B., Hoffman, A., Tie, G., Wang, R. and Messina, L.M. (2008) Cellular and molecular mechanism regulating blood flow recovery in acute versus gradual femoral artery occlusion are distinct in the mouse. J. Vasc. Surg. 48, 1546-1558
110. Lloyd, P.G., Yang, H.T. and Terjung, R.L. (2001) Arteriogenesis and angiogenesis in rat ischemic hindlimb: role of nitric oxide. Am. J. Physiol. Heart Circ. Physiol. 281, H2528-H2538
111. Dick, F., Li, J., Giraud, M.N., Kalka, C., Schmidli, J. and Tevaearai, H. (2008) Basic control of reperfusion effectively protects against reperfusion injury in a realistic rodent model of acute limb ischemia. Circulation 118, 1920-1928
112. Poling, J., Szibor, M., Schimanski, S., Ingelmann, M.E., Rees, W., Gajawada, P., Kochfar, Z., Lorchner, H., Salwig, I., Shin, J.Y. et al. (2011) Induction of smooth muscle cell migration during arteriogenesis is mediated by Rap2. Arterioscler. Thromb. Vasc. Biol. 31, 2297-2305
113. Paek, R., Chang, D.S., Brevetti, L.S., Rollins, M.D., Brady, S., Ursell, P.C., Hunt, T.K., Sarkar, R. and Messina, L.M. (2002) Correlation of a simple direct measurement of muscle pO(2) to a clinical ischemia index and histology in a rat model of chronic severe hindlimb ischemia. J. Vasc. Surg. 36, 172-179
114. Tang, G.L., Chang, D.S., Sarkar, R., Wang, R. and Messina, L.M. (2005) The effect of gradual or acute arterial occlusion on skeletal muscle blood flow, arteriogenesis, and inflammation in rat hindlimb ischemia. J. Vasc. Surg. 41, 312-320
115. Okamoto, N., Tanaka, A., Jung, K., Karasawa, K., Orito, K., Matsuda, A., Amagai, Y., Oida, K., Ohmori, K. and Matsuda, H. (2011) Silencing of int6 gene restores function of the ischaemic hindlimb in a rat model of peripheral arterial disease. Cardiovasc. Res. 92, 209-217
116. Tritsaris, K., Myren, M., Ditlev, S.B., Hubschmann, M.V., van der Blom, I., Hansen, A.J., Olsen, U.B., Cao, R., Zhang, J., Jia, T. et al. (2007) IL-20 is an arteriogenic cytokine that remodels collateral networks and improves functions of ischemic hind limbs. Proc. Natl. Acad. Sci. U.S.A. 104, 15364-15369
117. Ashitate, Y., Kim, S.H., Tanaka, E., Henary, M., Choi, H.S., Frangioni, J.V. and Flaumenhaft, R. (2012) Two-wavelength near-infrared fluorescence for the quantitation of drug antiplatelet effects in large animal model systems. J. Vasc. Surg. 56, 171-180
118. Sun, X., Cao, W., Cui, J., Wang, L., Ma, L., Wang, T., Peng, C., Tian, Z., Shi, S., Guo, S. and Tian, Y. (2013) An animal model of atherosclerotic plaque disruption and thrombosis in rabbit using pharmacological triggering to plaques induced by perivascular collar placement. Cardiovasc. Pathol. 22, 264-269
119. Zhuang, Z.W., Shi, J., Rhodes, J.M., Tsapakos, M.J. and Simons, M. (2011) Challenging the surgical rodent hindlimb ischemia model with the miniinterventional technique. J. Vasc. Interv. Radiol. 22, 1437-1446
120. Waters, R.E., Terjung, R.L., Peters, K.G. and Annex, B.H. (2004) Preclinical models of human peripheral arterial occlusive disease: implications for investigation of therapeutic agents. J. Appl. Physiol. 97, 773-780
121. Hoefer, I.E., van Royen, N., Rectenwald, J.E., Deindl, E., Hua, J., Jost, M., Grundmann, S., Voskuil, M., Ozaki, C.K., Piek, J.J. and Buschmann, I.R. (2004) Arteriogenesis proceeds via ICAM-1/Mac-1-mediated mechanisms. Circ. Res. 94, 1179-1185
122. Field, L.J. (1993) Transgenic mice in cardiovascular research. Annu. Rev. Physiol. 97-114
123. Wustmann, K., Zbinden, S., Windecker, S., Meier, B. and Seiler, C. (2003) Is there functional collateral flow during vascular occlusion in angiographically normal coronary arteries? Circulation 107, 2213-2220
124. Helisch, A. and Schaper, W. (2003) Arteriogenesis: the development and growth of collateral arteries. Microcirculation 10, 83-97
125. Fukino, K., Sata, M., Seko, Y., Hirata, Y. and Nagai, R. (2003) Genetic background influences therapeutic effectiveness of VEGF. Biochem. Biophys. Res. Commun. 310, 143-147
126. Scholz, D., Ziegelhoeffer, T., Helisch, A., Wagner, S., Friedrich, C., Podzuweit, T. and Schaper, W. (2002) Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J. Mol. Cell Cardiol. 34, 775-787
127. Chalothorn, D., Clayton, J.A., Zhang, H., Pomp, D. and Faber, J.E. (2007) Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains. Physiol. Genomics 30, 179-191
128. Dokun, A.O., Keum, S., Hazarika, S., Li, Y., Lamonte, G.M., Wheeler, F., Marchuk, D.A. and Annex, B.H. (2008) A quantitative trait locus (LSq-1) on mouse chromosome 7 is linked to the absence of tissue loss after surgical hindlimb ischemia. Circulation 117, 1207-1215
129. Sealock, R., Zhang, H., Lucitti, J.L., Moore, S.M. and Faber, J.E. (2014) Congenic fine-mapping identifies a major causal locus for variation in the native collateral circulation and ischemic injury in brain and lower extremity. Circ. Res. 114, 660-671
130. Limbourg, A., Korff, T., Napp, L.C., Schaper, W., Drexler, H. and Limbourg, F.P. (2009) Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia. Nat. Protoc. 4, 1737-1746
131. Hellingman, A.A., Bastiaansen, A.J., de Vries, M.R., Seghers, L., Lijkwan, M.A., Lowik, C.W., Hamming, J.F. and Quax, P.H. (2010) Variations in surgical procedures for hind limb ischaemia mouse models result in differences in collateral formation. Eur. J. Vasc. Endovasc. Surg. 40, 796-803
132. Kinlay, S. (2013) Outcomes for clinical studies assessing drug and revascularization therapies for claudication and critical limb ischemia in peripheral artery disease. Circulation 127, 1241-1250
133. Labs, K.H., Dormandy, J.A., Jaeger, K.A., Stuerzebecher, C.S. and Hiatt, W.R. (1999) Transatlantic conference on clinical trial guidelines in peripheral arterial disease: clinical trial methodology. basel PAD clinical trial methodology group. Circulation 100, e75-e81
134. Chalothorn, D. and Faber, J.E. (2010) Strain-dependent variation in collateral circulatory function in mouse hindlimb. Physiol. Genomics 42, 469-479
135. Stabile, E., Burnett, M.S., Watkins, C., Kinnaird, T., Bachis, A., la Sala, A., Miller, J.M., Shou, M., Epstein, S.E. and Fuchs, S. (2003) Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice. Circulation 108, 205-210
136. Skjeldal, S., Nordsletten, L., Kirkeby, O.J., Grogaard, B., Bjerkreim, I., Mowinckel, P., Torvik, A. and Reikeras, O. (1993) Perfusion in the anterior tibial muscle measured by laser Doppler flowmetry after graded periods of hindlimb ischemia in rats. Int. J. Microcirc. Clin. Exp. 12, 107-118
137. Ledermann, H.P., Heidecker, H.G., Schulte, A.C., Thalhammer, C., Aschwanden, M., Jaeger, K.A., Scheffler, K. and Bilecen, D. (2006) Calf muscles imaged at BOLD MR: correlation with TcPO2 and flowmetry measurements during ischemia and reactive hyperemia-initial experience. Radiology 241, 477-484
138. Westvik, T.S., Fitzgerald, T.N., Muto, A., Maloney, S.P., Pimiento, J.M., Fancher, T.T., Magri, D., Westvik, H.H., Nishibe, T., Velazquez, O.C. and Dardik, A. (2009) Limb ischemia after iliac ligation in aged mice stimulates angiogenesis without arteriogenesis. J. Vasc. Surg. 49, 464-473
139. Meisner, J.K., Niu, J., Sumer, S. and Price, R.J. (2013) Trans-illuminated laser speckle imaging of collateral artery blood flow in ischemic mouse hindlimb. J. Biomed. Opt. 18, 096011
140. Winship, I.R., Armitage, G.A., Ramakrishnan, G., Dong, B., Todd, K.G. and Shuaib, A. (2014) Augmenting collateral blood flow during ischemic stroke via transient aortic occlusion. J. Cereb. Blood Flow Metab. 34, 61-71
141. Toriumi, H., Tatarishvili, J., Tomita, M., Tomita, Y., Unekawa, M. and Suzuki, N. (2009) Dually supplied T-junctions in arteriolo-arteriolar anastomosis in mice: key to local hemodynamic homeostasis in normal and ischemic states? Stroke 40, 3378-3383
142. Goode, T.L. and Klein, H.J. (2002) Miniaturization: an overview of biotechnologies for monitoring the physiology and pathophysiology of rodent animal models. ILAR J. 43, 136-146
143. Silvestre, J.S., Mallat, Z., Duriez, M., Tamarat, R., Bureau, M.F., Scherman, D., Duverger, N., Branellec, D., Tedgui, A. and Levy, B.I. (2000) Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Circ. Res. 87, 448-452
144. Ikenaga, S., Hamano, K., Nishida, M., Kobayashi, T., Li, T.S., Kobayashi, S., Matsuzaki, M., Zempo, N. and Esato, K. (2001) Autologous bone marrow implantation induced angiogenesis and improved deteriorated exercise capacity in a rat ischemic hindlimb model. J. Surg. Res. 96, 277-283
145. Tateishi-Yuyama, E., Matsubara, H., Murohara, T., Ikeda, U., Shintani, S., Masaki, H., Amano, K., Kishimoto, Y., Yoshimoto, K., Akashi, H. et al. (2002) Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360, 427-435
146. Iglarz, M., Silvestre, J.S., Duriez, M., Henrion, D. and Levy, B.I. (2001) Chronic blockade of endothelin receptors improves ischemia-induced angiogenesis in rat hindlimbs through activation of vascular endothelial growth factor-no pathway. Arterioscler. Thromb. Vasc. Biol. 21, 1598-1603
147. Manninen, H.I. and Makinen, K. (2002) Gene therapy techniques for peripheral arterial disease. Cardiovasc. Intervent. Radiol. 25, 98-108
148. Takeshita, S., Isshiki, T., Mori, H., Tanaka, E., Tanaka, A., Umetani, K., Eto, K., Miyazawa, Y., Ochiai, M. and Sato, T. (1997) Microangiographic assessment of collateral vessel formation following direct gene transfer of vascular endothelial growth factor in rats. Cardiovasc. Res. 35, 547-552
149. Duan, J., Murohara, T., Ikeda, H., Sasaki, K., Shintani, S., Akita, T., Shimada, T. and Imaizumi, T. (2000) Hyperhomocysteinemia impairs angiogenesis in response to hindlimb ischemia. Arterioscler Thromb. Vasc. Biol. 20, 2579-2585
150. Zhuang, Z.W., Gao, L., Murakami, M., Pearlman, J.D., Sackett, T.J., Simons, M. and de Muinck, E.D. (2006) Arteriogenesis: noninvasive quantification with multi-detector row CT angiography and three-dimensional volume rendering in rodents. Radiology 240, 698-707
151. Duvall, C.L., Taylor, W.R., Weiss, D. and Guldberg, R.E. (2004) Quantitative microcomputed tomography analysis of collateral vessel development after ischemic injury. Am. J. Physiol. Heart Circ. Physiol. 287, H302-H310
152. Cristofaro, B., Shi, Y., Faria, M., Suchting, S., Leroyer, A.S., Trindade, A., Duarte, A., Zovein, A.C., Iruela-Arispe, M.L., Nih, L.R. et al. (2013) Dll4-Notch signaling determines the formation of native arterial collateral networks and arterial function in mouse ischemia models. Development 140, 1720-1729
153. de Lussanet, Q.G., van Golde, J.C., Beets-Tan, R.G., de Haan, M.W., Zaar, D.V., Post, M.J., Huijberts, M.S., Schaper, N.C., van Engelshoven, J.M. and Backes, W.H. (2006) Magnetic resonance angiography of collateral vessel growth in a rabbit femoral artery ligation model. NMR Biomed. 19, 77-83
154. Hershey, J.C., Baskin, E.P., Glass, J.D., Hartman, H.A., Gilberto, D.B., Rogers, I.T. and Cook, J.J. (2001) Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis. Cardiovasc. Res. 49, 618-625
155. Deindl, E., Buschmann, I., Hoefer, I.E., Podzuweit, T., Boengler, K., Vogel, S., van Royen, N., Fernandez, B. and Schaper, W. (2001) Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ. Res. 89, 779-786
156. Heil, M., Eitenmuller, I., Schmitz-Rixen, T. and Schaper, W. (2006) Arteriogenesis versus angiogenesis: similarities and differences. J. Cell Mol. Med. 10, 45-55
157. Pipp, F., Boehm, S., Cai, W.J., Adili, F., Ziegler, B., Karanovic, G., Ritter, R., Balzer, J., Scheler, C., Schaper, W. and Schmitz-Rixen, T. (2004) Elevated fluid shear stress enhances postocclusive collateral artery growth and gene expression in the pig hind limb. Arterioscler. Thromb. Vasc. Biol. 24, 1664-1668
158. Topper, J.N. and Gimbrone, Jr, M.A. (1999) Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype. Mol. Med. Today 5, 40-46
159. Bao, X., Lu, C. and Frangos, J.A. (1999) Temporal gradient in shear but not steady shear stress induces PDGF-A and MCP-1 expression in endothelial cells: role of NO, NF kappa B, and egr-1. Arterioscler. Thromb. Vasc. Biol. 19, 996-1003
160. Chiu, J.J., Wung, B.S., Hsieh, H.J., Lo, L.W. and Wang, D.L. (1999) Nitric oxide regulates shear stress-induced early growth response-1. Expression via the extracellular signal-regulated kinase pathway in endothelial cells. Circ. Res. 85, 238-246
161. Nagel, T., Resnick, N., Atkinson, W.J., Dewey, Jr, C.F. and Gimbrone, Jr, M.A. (1994) Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J. Clin. Invest. 94, 885-891
162. Garcia-Cardena, G., Comander, J., Anderson, K.R., Blackman, B.R. and Gimbrone, Jr, M.A. (2001) Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc. Natl. Acad. Sci. U.S.A. 98, 4478-4485
163. Harada, K., Grossman, W., Friedman, M., Edelman, E.R., Prasad, P.V., Keighley, C.S., Manning, W.J., Sellke, F.W. and Simons, M. (1994) Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J. Clin. Invest. 94, 623-630
164. Roth, D.M., White, F.C., Mathieu-Costello, O., Guth, B.D., Heusch, G., Bloor, C.M. and Longhurst, J.C. (1987) Effects of left circumflex ameroid constrictor placement on adrenergic innervation of myocardium. Am. J. Physiol. 253 (6 Pt), H1425-H1434
165. Baffour, R., Garb, J.L., Kaufman, J., Berman, J., Rhee, S.W., Norris, M.A. and Friedmann, P. (2000) Angiogenic therapy for the chronically ischemic lower limb in a rabbit model. J. Surg. Res. 93, 219-229
166. Pu, L.Q., Jackson, S., Lachapelle, K.J., Arekat, Z., Graham, A.M., Lisbona, R., Brassard, R., Carpenter, S. and Symes, J.F. (1994) A persistent hindlimb ischemia model in the rabbit. J. Invest. Surg. 7, 49-60
167. Rivard, A., Fabre, J.E., Silver, M., Chen, D., Murohara, T., Kearney, M., Magner, M., Asahara, T. and Isner, J.M. (1999) Age-dependent impairment of angiogenesis. Circulation 99, 111-120
168. Hiatt, W.R., Hirsch, A.T., Regensteiner, J.G. and Brass, E.P. (1995) Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Circulation 92, 614-621
169. Sieminski, D.J., Cowell, L.L., Montgomery, P.S., Pillai, S.B. and Gardner, A.W. (1997) Physical activity monitoring in patients with peripheral arterial occlusive disease. J. Cardiopulm. Rehabil. 17, 43-47
170. Garg, P.K., Tian, L., Criqui, M.H., Liu, K., Ferrucci, L., Guralnik, J.M., Tan, J. and McDermott, M.M. (2006) Physical activity during daily life and mortality in patients with peripheral arterial disease. Circulation 114, 242-248
171. Gardner, A.W. and Afaq, A. (2008) Management of lower extremity peripheral arterial disease. J. Cardiopulm. Rehabil. Prev. 28, 349-357
172. Regensteiner, J.G., Gardner, A. and Hiatt, W.R. (1997) Exercise testing and exercise rehabilitation for patients with peripheral arterial disease: status in 1997. Vasc. Med. 2, 147-155
173. Tjon, J.A. and Riemann, L.E. (2001) Treatment of intermittent claudication with pentoxifylline and cilostazol. Am. J. Health Syst. Pharm. 58, 485-493
174. Murphy, T.P., Cutlip, D.E., Regensteiner, J.G., Mohler, E.R., Cohen, D.J., Reynolds, M.R., Massaro, J.M., Lewis, B.A., Cerezo, J., Oldenburg, N.C. et al. (2012) Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation 125, 130-139
175. Ziegler, M.A., Distasi, M.R., Bills, R.G., Miller, S.J., Alloosh, M., Murphy, M.P., Akingba, A.G., Sturek, M., Dalsing, M.C. and Unthank, J.L. (2010) Marvels, mysteries, and misconceptions of vascular compensation to peripheral artery occlusion. Microcirculation 17, 3-20
176. Dawson, D.L., Cutler, B.S., Hiatt, W.R., Hobson, II, R.W., Martin, J.D., Bortey, E.B., Forbes, W.P. and Strandness, Jr, D.E. (2000) A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am. J. Med. 109, 523-530
177. Belch, J.J., Ray, S., Rajput-Ray, M., Engeset, J., Fagrell, B., Lepantalo, M., McKay, A., Mackay, I.R., Ostergren, J., Ruckley, C.V. and Salenius, J. (2011) The Scottish-Finnish-Swedish PARTNER study of taprostene versus placebo treatment in patients with critical limb ischemia. Int. Angiol. 30, 150-155
178. Baltgalvis, K.A., White, K., Li, W., Claypool, M.D., Lang, W., Alcantara, R., Singh, B.K., Friera, A.M., McLaughlin, J., Hansen, D. et al. (2014) Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice. Am. J. Physiol. Heart. Circ. Physiol. 306, H1128-H1145
179. Zhang, B., Adesanya, T.M., Zhang, L., Xie, N., Chen, Z., Fu, M., Zhang, J., Zhang, J., Tan, T., Kilic, A. et al. (2014) Delivery of placenta-derived mesenchymal stem cells ameliorates ischemia induced limb injury by immunomodulation. Cell Physiol. Biochem. 34, 1998-2006
180. Clarke, K.A. and Still, J. (1999) Gait analysis in the mouse. Physiol. Behav. 66, 723-739
181. Clarke, K.A., Smart, L. and Still, J. (2001) Ground reaction force and spatiotemporal measurements of the gait of the mouse. Behav. Res. Methods Instrum. Comput. 33, 422-426
182. Crowther, R.G., Spinks, W.L., Leicht, A.S., Sangla, K., Quigley, F. and Golledge, J. (2008) Effects of a long-term exercise program on lower limb mobility, physiological responses, walking performance, and physical activity levels in patients with peripheral arterial disease. J. Vasc. Surg. 47, 303-309
183. Crowther, R.G., Spinks, W.L., Leicht, A.S., Quigley, F. and Golledge, J. (2008) Intralimb coordination variability in peripheral arterial disease. Clin. Biomech. 23, 357-364
184. Crowther, R.G., Spinks, W.L., Leicht, A.S., Quigley, F. and Golledge, J. (2007) Relationship between temporal-spatial gait parameters, gait kinematics, walking performance, exercise capacity, and physical activity level in peripheral arterial disease. J. Vasc. Surg. 45, 1172-1178
185. Bath, P.M. and Gray, L.J. (2009) Systematic reviews as a tool for planning and interpreting trials. Int. J. Stroke 4, 23-27
186. Chen, Z., Cheng, K., Walton, Z., Wang, Y., Ebi, H., Shimamura, T., Liu, Y., Tupper, T., Ouyang, J., Li, J. et al. (2012) A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response. Nature 483, 613-617
187. Nardella, C., Lunardi, A., Patnaik, A., Cantley, L.C. and Pandolfi, P.P. (2011) The APL paradigm and the "co-clinical trial" project. Cancer Discov. 1, 108-116